Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$278M |
| 2 |
Exxon Mobil
XOM
|
+$270M |
| 3 |
Verizon
VZ
|
+$141M |
| 4 |
Yum China
YUMC
|
+$135M |
| 5 |
Chevron
CVX
|
+$122M |
Top Sells
Sector Composition
| 1 | Financials | 17.74% |
| 2 | Technology | 15.29% |
| 3 | Industrials | 12.37% |
| 4 | Healthcare | 11.81% |
| 5 | Consumer Discretionary | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Great Elm Group
GEG
$81.2M
| $243K | ﹤0.01% |
121,480
-3,196
| -3% | -$6.39K |
|
3202
CleanSpark
CLSK
$2.79B
| $242K | ﹤0.01% |
+75,944
| New | +$242K |
|
3203
First US Bancshares
FUSB
$66.9M
| $240K | ﹤0.01% |
30,233
+252
| +0.8% | +$2K |
|
3204
US Global Investors
GROW
$31.8M
| $238K | ﹤0.01% |
82,960
+26,848
| +48% | +$77K |
|
3205
fuboTV
FUBO
$1.36B
| $235K | ﹤0.01% |
65,983
| – | – |
|
3206
Kanzhun
BZ
$11.2B
| $234K | ﹤0.01% |
+13,864
| New | +$234K |
|
|
TOUR
3207
Tuniu
TOUR
$109M
| $234K | ﹤0.01% |
353,603
-27,925
| -7% | -$18.5K |
|
3208
Viridian Therapeutics
VRDN
$1.62B
| $234K | ﹤0.01% |
11,398
| – | – |
|
3209
CB Financial Services
CBFV
$166M
| $233K | ﹤0.01% |
+10,703
| New | +$233K |
|
3210
Informatica
INFA
$7.55B
| $232K | ﹤0.01% |
+11,560
| New | +$232K |
|
3211
Beasley Broadcasting Group
BBGI
$8.8M
| $229K | ﹤0.01% |
10,579
-1,082
| -9% | -$23.4K |
|
3212
C4 Therapeutics
CCCC
$187M
| $229K | ﹤0.01% |
+26,078
| New | +$229K |
|
3213
Cartesian Therapeutics
RNAC
$258M
| $229K | ﹤0.01% |
+4,655
| New | +$229K |
|
3214
Coffee Holding Co
JVA
$23.8M
| $228K | ﹤0.01% |
91,382
-15,757
| -15% | -$39.3K |
|
3215
Seres Therapeutics
MCRB
$151M
| $228K | ﹤0.01% |
1,774
-25,364
| -93% | -$3.26M |
|
3216
Precigen
PGEN
$1.18B
| $226K | ﹤0.01% |
107,100
+35,248
| +49% | +$74.4K |
|
3217
Zedge
ZDGE
$40.6M
| $223K | ﹤0.01% |
94,327
-15,680
| -14% | -$37.1K |
|
3218
IAC Inc
IAC
$2.88B
| $222K | ﹤0.01% |
4,876
+11
| +0.2% | +$501 |
|
|
AENZ
3219
DELISTED
Aenza S.A.A. American Depositary Shares (each representing fifteen (15) Common Shares)
AENZ
| $221K | ﹤0.01% |
101,668
| – | – |
|
3220
Dianthus Therapeutics
DNTH
$1.2B
| $216K | ﹤0.01% |
9,562
-318
| -3% | -$7.18K |
|
3221
Pioneer Bancorp
PBFS
$336M
| $216K | ﹤0.01% |
22,692
+5,540
| +32% | +$52.7K |
|
|
PTNR
3222
DELISTED
Partner Communications
PTNR
| $216K | ﹤0.01% |
29,361
| – | – |
|
3223
Compass
COMP
$4.8B
| $214K | ﹤0.01% |
92,306
-55,793
| -38% | -$129K |
|
3224
Bank Of The James
BOTJ
$70.2M
| $213K | ﹤0.01% |
16,834
+2,653
| +19% | +$33.6K |
|
3225
Affirm
AFRM
$27.5B
| $212K | ﹤0.01% |
11,347
+1,077
| +10% | +$20.1K |
|